RxDoctor Payments Data

Jamie Lohr, MD

Pediatric Cardiology · Minneapolis, MNNPI 1811916125

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $18,326 of the $18,491 with a category attached, or 99.1%. Abbott accounts for 99.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $6,480 and has fallen 83.6% since, to $1,062 in 2024.

$18,491in general payments, 2019–2025

Across 36 payments — averaging $513.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$18K
  • Getinge USA Sales, LLC$96
  • Johnson & Johnson$39
  • Medtronic$29
$40,937in research payments, 2019–2025

Across 3 payments — averaging $13,646 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$41K

What the payments were for

  • Consulting fees$18,32699%
  • Food & beverage$1651%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott31$18,326
Getinge USA Sales, LLC2$96
Johnson & Johnson1$39
Medtronic2$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,491 in reported general payments places this provider in the 85th percentile of 41 pediatric cardiology providers in Minnesota.

See all pediatric cardiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$7,050
Medicare patients
41
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin35$44,218
EntrestoSacubitril/Valsartan14$20,053
Metoprolol Succinate27$842
Spironolactone59$586
Losartan Potassium28$282
Furosemide29$206
Carvedilol19$80
Amoxicillin13$51

Paid to pharmacies, not to this prescriber.

Other pediatric cardiology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →